The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma

Molecular Carcinogenesis

Volumn 27, Issue 3, 2000, Pages 237-244

  Sasaki, Masahiro ^a   Dahiya, Rajvir ^a   Fujimoto, Seiichiro ^b   Ishikawa, Mutuo ^c   Oshimura, Mitsuo ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

Androgen receptor gene; CAG repeat; Carcinogenesis; Endometrial carcinoma

Indexed keywords

ANDROGEN RECEPTOR; DNA; RNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; GENE LOCUS; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR GENE; TRINUCLEOTIDE REPEAT; UTERUS CANCER; X CHROMOSOME;

ALLELES; CLONING, MOLECULAR; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; EXONS; FEMALE; HUMANS; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS; UTERINE NEOPLASMS;

EID: 0034015831     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200003)27:3<237::AID-MC11>3.0.CO;2-0     Document Type: Article

References (38)

1. Lentz SS. Endocrine therapy of endometrial cancer. Cancer Treat Res 1998;94:89-106
2. Horie K, Takakura K, Imai K, Liao S, Mori T. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum Reprod 1992;7: 1461-1466.
3. Hackenberg R, Beck S, Filmer A, et al. Androgen responsiveness of the new human endometrial cancer cell line MFE-296. Int J Cancer 1994;57:117-122.
4. Centola GM. Inhibition of endometrial carcinoma cell cultures by a synthetic androgen. Cancer Res 1985;45: 6264-6267.
5. Kuiper GG, Faber PW, van Rooij HC, et al. Structural organization of the human androgen receptor gene. J Mol Endocrinol 1989;2:1-4.
6. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988;240:327-330.
7. Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res 1992;20:1427.
8. Sasaki, M, Shiono H, Shimizu K, Fukushima T. Several STR loci on sex chromosomes. Advance in research on DNA polymorphisms. Tokyo, Toyo Shoten, 1997. p 133-134.
9. Tilley WD, Marcelli W, Wilson JD, McPhaul MJ. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Nat Acad Sci, USA 1989;86: 327-331.
10. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset: A sex-linked recessive trait. Neurology 1968;18:671-680.
11. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fishbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79.
12. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-3186.
13. Kang S, Ohshima K, Shimizu M, Amirhaeri S, Wells RD. Pausing of DNA synthesis in vitro at specific loci in CTG and CGG triplet repeats from human hereditary disease genes. J Biol Chem 1995;270:27014-27021.
14. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-1940.
15. Newmark JR, Hardy DO, Tonb DC, et al. Androgen receptor gene mutations in human prostate cancer. Proc Nat Acad Sci, USA 1992;89:6319-6323.
16. Stanford JL, Just JJ, Gibbs M, et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997;57:1194-1198.
17. Hardy DO, Scher HI, Bogenreider T, et al. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-4405.
18. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-1762.
19. Sasaki M, Fukushima T, Shiono H. Analysis of sex chromosomal DNA markers by a molecular biological method and its application to forensic medicine. Japan J Legal Med 1995;49:70-79.
20. Sasaki M, Shiono H. ABO genotyping of suspects from sperm DNA isolated from the post-coital samples of sexual crimes. J Forensic Sci 1996;41:275-278.
21. Burks RT, Kessis TD, Cho KR, Hedrick L. Microsatellite instability in endometrial carcinoma. Oncogene 1994;9: 1163-1166.
22. Busque L, Zhu J, DeHart D, et al. An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. Nucleic Acids Res 1994; 22:697-698.
23. Hamblen EC. Androgen treatment of woman. South Med J 1957;50:743-748.
24. Hackenberg R, Hawighorst Th, Filmer A, et al. Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells. J Steroid Biochem Mol Biol 1992;43:599-607.
25. Bolund CR, Troncale FJ. Familial colonic cancer in the absence of antecedent polyposis. Ann Intern Med 1984; 100:700-701.
26. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-685.
27. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993;53:5100-5103.
28. Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J, Shibata D. Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 1994;86:1216-1221.
29. Heiland A, Borresen-Dale AL, Peltomaki P, et al. Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer 1997;70:499-501.
30. Kobayashi K, Sagae S, Kudo R, Saito H, Koi S, Nakamura, Y. Microsatellite instability in endometrial carcinomas: frequent replication errors in tumors of early onset and/or of poorly differentiated type. Genes Chromosomes Cancer 1995;14:128-132.
31. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
32. Kazemi-Esfarjani P, Trifiro MA, Pinsky L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenetic relevance for the (CAG)n expanded neuronopathies. Hum Mol Genet 1995;4:523-527.
33. Zhuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha IA-voltage-dependent calcium channel. Nat Genet 1997;15:62-69.
34. Trepicchio WL, Krontiris TG. Members of the rel/NF-kappa B family of transcriptional regulatory proteins bind the Hras1 minisatellite DNA sequence. Nucleic Acids Res 1992;20: 2427-2434.
35. Lidereau R, Escot C, Theillet C, et al. High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients. J Natl Cancer Inst 1986;77: 697-701.
36. Bennett ST, Wilson AJ, Esposito L, et al. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet 1997;17:350-352.
37. Kennedy GC, German MS, Rutter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet 1995;9:293-298.
38. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274: 1527-1531.